Semaglutide for the investigation of metabolic research models [PMID: 34942372] Laboratory literature summary: Semaglutide for the investigation of metabolic research models
Unlike most of the companies in our ranks, BI actually increased its workforce in 2007, adding 1,400 people
Triazolam in patients with obstructive sleep apnea
Adding tirzepatide to an already sluggish gallbladder creates more stagnation
In addition to treating diseases by modulating palmitoylation-related enzymes, therapeutic agents can target specific palmitoylated cysteine residues, such as C176/178, H-151, NO2-FAs or nitrofuran molecules, which can block STING palmitoylation modification by covalently modifying the Cys91 residue of STING, inhibiting type I interferon signaling, and providing a new therapeutic target for STING-associated diseases by blocking STING palmitoylation and inhibiting type I interferon signaling (103, 251)
D., Hanna, S